- Home
- MDCX vs PLUR Comparison
MDCX vs PLUR Comparison
Compare MDCX & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDCX
- PLUR
- Stock Information
- Founded
- MDCX 2008
- PLUR 2001
- Country
- MDCX Canada
- PLUR Israel
- Employees
- MDCX N/A
- PLUR N/A
- Industry
- MDCX
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDCX
- PLUR Health Care
- Exchange
- MDCX Nasdaq
- PLUR Nasdaq
- Market Cap
- MDCX 48.4M
- PLUR 41.9M
- IPO Year
- MDCX N/A
- PLUR N/A
- Fundamental
- Price
- MDCX $2.60
- PLUR $4.36
- Analyst Decision
- MDCX Strong Buy
- PLUR
- Analyst Count
- MDCX 2
- PLUR 0
- Target Price
- MDCX $23.50
- PLUR N/A
- AVG Volume (30 Days)
- MDCX 383.9K
- PLUR 15.5K
- Earning Date
- MDCX 05-12-2025
- PLUR 05-13-2025
- Dividend Yield
- MDCX N/A
- PLUR N/A
- EPS Growth
- MDCX N/A
- PLUR N/A
- EPS
- MDCX N/A
- PLUR N/A
- Revenue
- MDCX N/A
- PLUR $1,034,000.00
- Revenue This Year
- MDCX N/A
- PLUR $472.39
- Revenue Next Year
- MDCX N/A
- PLUR $254.29
- P/E Ratio
- MDCX N/A
- PLUR N/A
- Revenue Growth
- MDCX N/A
- PLUR 203.23
- 52 Week Low
- MDCX $1.80
- PLUR $3.33
- 52 Week High
- MDCX $8.94
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- MDCX N/A
- PLUR 42.18
- Support Level
- MDCX N/A
- PLUR $4.30
- Resistance Level
- MDCX N/A
- PLUR $4.62
- Average True Range (ATR)
- MDCX 0.00
- PLUR 0.29
- MACD
- MDCX 0.00
- PLUR -0.08
- Stochastic Oscillator
- MDCX 0.00
- PLUR 19.29
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.